Repligen Corporation Common Stock vs Warner Music Group Corp — how do they compare? Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B), while Warner Music Group Corp trades at $29.15 (market cap $15.12B). The key difference: Warner Music Group Corp is the larger of the two by market cap, and Warner Music Group Corp pays a 2.77% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Warner Music Group Corp for 97 Days on average.
| RGEN | WMG | |
|---|---|---|
Market Cap | $11.31B | $15.12B |
Volume | 1,216,919 | 1,727,670 |
Sector | Health | Media |
52-Week High | $194.57 | $34.72 |
52-Week Low | $102.87 | $23.65 |
Typical Hold Time | 0 Days | 97 Days |
Enterprise Value | $11.20B | $19.42B |
Dividend Yield | — | 2.77% |
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Warner Music Group (WMG) trades at $28.91, up 0.91% on the day, with a bullish technical signal from moving averages. The stock shows strong analyst support with a consensus price target of $39.50, representing significant upside. Recent earnings have beaten expectations in two of the last three quarters, with Q3 2026 results pending. The company maintains robust profitability with a 45.77% gross margin and 9.2% net margin, while revenue growth continues steadily from $6.71B in 2025 to a projected $7.3B in 2026.
WMG presents a compelling investment case with strong fundamentals, positive analyst sentiment, and strategic positioning in the evolving music industry, particularly through AI partnerships. However, risks include recent leadership changes, ongoing copyright litigation, and valuation metrics that appear elevated relative to historical norms. The stock's current price near recent highs suggests limited near-term upside without further positive catalysts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →